Written Question·Department of Health and Social Care·UIN 39290

Coronavirus: Drugs

Tabled: 18 March 2025
Answered: 26 March 2025

Question

David Chadwick

Liberal DemocratBrecon, Radnor and Cwm Tawe

To ask the Secretary of State for Health and Social Care, whether he has had discussions with NICE on the potential use of PEMGARDA to protect clinically vulnerable people against covid-19 in emergency situations.

Answer

Karin Smyth
It is critical that medicines used in the United Kingdom are safe and effective and as such, medicines cannot be marketed in the UK without a marketing authorisation. These are granted by the Medicines and Healthcare products Regulatory Agency (MHRA) whic...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 39290) →